Skip to Content

RDY 226 (Lamotrigine (Chewable, Dispersible) 25 mg)

Pill with imprint RDY 226 is White, Capsule-shape and has been identified as Lamotrigine (Chewable, Dispersible) 25 mg. It is supplied by Dr. Reddy’s Laboratories Inc..

Lamotrigine is used in the treatment of bipolar disorder; borderline personality disorder; epilepsy; seizure prevention; schizoaffective disorder (and more), and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 25 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for RDY 226

Lamotrigine (Chewable, Dispersible)

Imprint:
RDY 226
Strength:
25 mg
Color:
White
Size:
13.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Triazine anticonvulsants
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Dr. Reddy’s Laboratories Inc.
Inactive Ingredients:
silicon dioxide
crospovidone
magnesium stearate
mannitol
microcrystalline cellulose
corn starch
magnesium silicate
black currant
Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide